Masimo (1MASI) Stock Overview
Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 1MASI from our risk checks.
1MASI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Masimo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$123.85 |
| 52 Week High | US$131.25 |
| 52 Week Low | US$128.50 |
| Beta | 1.26 |
| 1 Month Change | -4.29% |
| 3 Month Change | 4.08% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1MASI | IT Medical Equipment | IT Market | |
|---|---|---|---|
| 7D | 0.5% | -16.7% | -0.7% |
| 1Y | n/a | -37.4% | 25.6% |
Return vs Industry: Insufficient data to determine how 1MASI performed against the Italian Medical Equipment industry.
Return vs Market: Insufficient data to determine how 1MASI performed against the Italian Market.
Price Volatility
| 1MASI volatility | |
|---|---|
| 1MASI Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in IT Market | 7.7% |
| 10% least volatile stocks in IT Market | 2.4% |
Stable Share Price: 1MASI has not had significant price volatility in the past 3 months compared to the Italian market.
Volatility Over Time: 1MASI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 3,600 | Katie Szyman | www.masimo.com |
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions.
Masimo Corporation Fundamentals Summary
| 1MASI fundamental statistics | |
|---|---|
| Market cap | €6.68b |
| Earnings (TTM) | -€207.79m |
| Revenue (TTM) | €1.89b |
Is 1MASI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1MASI income statement (TTM) | |
|---|---|
| Revenue | US$2.18b |
| Cost of Revenue | US$1.11b |
| Gross Profit | US$1.08b |
| Other Expenses | US$1.32b |
| Earnings | -US$240.30m |
Last Reported Earnings
Sep 27, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.47 |
| Gross Margin | 49.33% |
| Net Profit Margin | -11.01% |
| Debt/Equity Ratio | 69.0% |
How did 1MASI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 19:13 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/09/27 |
| Annual Earnings | 2024/12/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Masimo Corporation is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Charley Jones | Barrington Research Associates, Inc. |
| Ravi Misra | Berenberg |